New schemes of insulin treatment in children and adolescents with type 1 diabetes mellitus attending a public hospital;Nuevos esquemas de tratamiento con insulina en niños y adolescentes con diabetes mellitus tipo 1 (DM1) en un hospital público

Revista Chilena de Pediatria

Volumn 75, Issue 6, 2004, Pages 520-529

  Codner, D Ethel ^a   Mericq, G Verónica ^a   Román, R Rossana ^a   Hrlic, Irene ^a   Martínez, A Alejandro ^a   Unanue, M Nancy ^a   Cáceres, V Jeannette ^a   Avila, A Alejandra ^a   Cassorla, G Fernando ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

Adolescence; Diabetes mellitus; Insulin; Intensive treatment

Indexed keywords

HEMOGLOBIN A1C; INSULIN; INSULIN GLARGINE; ISOPHANE INSULIN;

ADOLESCENT; ARTICLE; CARBOHYDRATE INTAKE; CONTROLLED STUDY; CORRELATION ANALYSIS; EDUCATION PROGRAM; FEMALE; HEALTH CARE DELIVERY; HUMAN; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; PATIENT EDUCATION; PUBLIC HOSPITAL; SCHOOL CHILD;

EID: 15944421225     PISSN: 03704106     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993; 329: 977-86.
2. UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-53.
3. The Diabetes Control and Complications Trial Research Group: Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin- dependent diabetes mellitus: Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group. J Pediatr 1994; 125: 177-88.
4. The Diabetes Control and Complications Trial Research Group: Beneficial effects of intensive therapy of diabetes during adolescence: Outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT). J Pediatr 2001; 139: 804-12.
5. The Diabetes Control and Complications Trial Research Group: Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. N Engl J Med 2000; 342: 381-9.
6. Hirsch IB: Intensive treatment of type 1 diabetes. Med Clin North Am 1998; 82: 689-719.
7. Codner E, Mericq V, García H, et al: Resultados de un programa multidisciplinario de tratamiento intensificado de la Diabetes Mellitus tipo 1 (DM1) en un Hospital Público. Rev Méd Chile 2003; 131: 857-64.
8. Chase HP, Lockspeiser T, Peery B, et al: The impact of the diabetes control and complications trial and humalog insulin on glycohemoglobin levels and severe hypoglycemia in type 1 diabetes. Diabetes Care 2001; 24: 430-4.
9. Franz MJ, Horton ES, Bantle JP, et al: Nutrition principles for the management of diabetes and related complications. Diabetes Care 1994; 17: 490-518.
10. Franz MJ, Bantle JP, Beebe CA, et al: Evidence-Based Nutrition Principles and Recommendations for the Treatment and Prevention of Diabetes and Related Complications. Diabetes Care 2002; 25: 148-98.
11. Waldron S, Hanas R, Palmvig B: How do we educate young people to balance carbohydrate intake with adjustments of insulin? Horm Res 2002; 57: 62-5.
12. Warshaw H, Bolderman KM: Practical Carbohydrate Count: A How-to-Teach Guide for Health Professionals: McGraw-Hill, 2003.
13. Ogden CL, Kuczmarski RJ, Flegal KM, et al: Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics 2002; 109: 45-60.
14. Marshall WA, Tanner JM: Variations in pattern of pubertal changes in girls. Arch Dis Child 1969; 44: 291-303.
15. Marshall WA, Tanner JM: Variations in the pattern of pubertal changes in boys. Arch Dis Child 1970; 45: 13-23.
16. Codner E: Síndrome hiperglicémico. En: Beas F., ed. Endocrinología del niño y el adolescente. Santiago: Editorial Mediterráneo 2002; 235-57.
17. Gillies PS, Figgitt DP, Lamb HM: Insulin glargine. Drugs 2000; 59: 253-60.
18. Chase HP, Dixon B, Pearson J, et al: Reduced hypoglycemic episodes and improved glycemic control in children with type 1 diabetes using insulin glargine and neutral protamine Hagedorn insulin. J Pediatr 2003; 143: 737-40.
19. Goonetilleke R, Pollitzer M, Mann N: Insulin for toddlers with difficult diabetes. Diabetes Care 2004; 27: 1505.
20. Lalli C, Ciofetta M, Del Sindaco P, et al: Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime. Diabetes Care 1999; 22: 468-77.
21. Rossetti P, Pampanelli S, Fanelli C, et al: Intensive replacement of basal insulin in patients with type 1 diabetes given rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime. Diabetes Care 2003; 26: 1490-6.
22. Donaghue KC, Fairchild JM, Craig ME, et al: Do all prepubertal years of diabetes duration contribute equally to diabetes complications? Diabetes Care 2003; 26: 1224-9.
23. Svensson M, Eriksson JW, Dahlquist G: Early glycemic control, age at onset, and development of microvascular complications in childhood-onset type 1 diabetes: a population-based study in northern Sweden. Diabetes Care 2004; 27: 955-62.
24. Bolli GB: How to ameliorate the problem of hypoglycemia in intensive as well as nonintensive treatment of type 1 diabetes. Diabetes Care 1999; 22: 43-52.
25. Wysocki T, Harris MA, Mauras N, et al: Absence of adverse effects of severe hypoglycemia on cognitive function in school-aged children with diabetes over 18 months. Diabetes Care 2003; 26: 1100-5.
26. Chase HP: Glycemic control in prepubertal years. Diabetes Care 2003; 26: 1304-5.
27. Rosilio M, Cotton JB, Wieliczko MC, et al: Factors associated with glycemic control. A cross-sectional nationwide study in 2,579 French children with type 1 diabetes. The French Pediatric Diabetes Group. Diabetes Care 1998; 21: 1146-53.
28. Codner E, Barrera A, Mook-Kanamori D, et al: Ponderal Gain, Waist-to-hip Ratio and Pubertal Development in Girls with Type 1 Diabetes Mellitus. Pediatric Diabetes 2004; 5: 182-9.
29. Danne T, Mortensen HB, Hougaard P, et al: Persistent differences among centers over 3 years in glycemic control and hypoglycemia in a study of 3,805 children and adolescents with type 1 diabetes from the Hvidore Study Group. Diabetes Care 2001; 24: 1342-7.
30. Levine BS, Anderson BJ, Butler DA, Antisdel JE, Brackett J, Laffel LM: Predictors of glycemic control and short-term adverse outcomes in youth with type 1 diabetes. J Pediatr 2001; 139: 197-203.
31. Martínez A, Fernández D, Mook-Kanamori D, Codner E: Abnormal eating behaviour and insulin omisión in adolescents with diabetes mellitus type 1. Association with glycemic control and body mass index", XVI Annual Meeting of the Latin-American Society of Pediatric Endocrinology (SLEP), Cancún, México, 2003.
32. Grey M, Boland EA, Davidson M, Yu C, Sullivan-Bolyai S, Tamborlane WV: Short-term effects of coping skills training as adjunct to intensive therapy in adolescents. Diabetes Care 1998; 21: 902-8.
33. Laffel LM, Vangsness L, Connell A, Goebel-Fabbri A, Butler D, Anderson BJ: Impact of ambulatory, family-focused teamwork intervention on glycemic control in youth with type 1 diabetes. J Pediatr 2003; 142: 409-16.
34. Svoren BM, Butler D, Levine BS, Anderson BJ, Laffel LM: Reducing acute adverse outcomes in youths with type 1 diabetes: a randomized, controlled trial. Pediatrics 2003; 112: 914-22.